Zhejiang Shengda Pharm (603079) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.028x

Based on the latest financial reports, Zhejiang Shengda Pharm (603079) has a cash flow conversion efficiency ratio of 0.028x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥45.27 Million ≈ $6.62 Million USD) by net assets (CN¥1.60 Billion ≈ $234.73 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Zhejiang Shengda Pharm liquidity coverage in days to measure how many days the company can operate on defensive assets alone.

Zhejiang Shengda Pharm - Cash Flow Conversion Efficiency Trend (2012–2025)

This chart illustrates how Zhejiang Shengda Pharm's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Zhejiang Shengda Pharm Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Zhejiang Shengda Pharm ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Morguard Real Estate Investment Trust TO:MRT-UN	0.006x
Jiin Yeeh Ding Enterprise Co Ltd TWO:8390	0.026x
Lihe Technology SHE:300800	-0.005x
Kung Long Batteries Industrial Co Ltd TW:1537	0.106x
Sungwoo Hitech Co. Ltd KQ:015750	0.037x
Silence Therapeutics PLC NASDAQ:SLN	-0.147x
Bell Financial Group Ltd AU:BFG	0.188x
Antibiotice Ia RO:ATB	-0.042x

Annual Cash Flow Conversion Efficiency for Zhejiang Shengda Pharm (2012–2025)

The table below shows the annual cash flow conversion efficiency of Zhejiang Shengda Pharm from 2012 to 2025. For the full company profile with market capitalisation and key ratios, see 603079 market cap overview.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥1.61 Billion ≈ $236.30 Million	CN¥138.88 Million ≈ $20.32 Million	0.086x	-25.32%
2024-12-31	CN¥1.28 Billion ≈ $187.89 Million	CN¥147.88 Million ≈ $21.64 Million	0.115x	+127.05%
2023-12-31	CN¥1.27 Billion ≈ $185.84 Million	CN¥64.42 Million ≈ $9.43 Million	0.051x	+67.37%
2022-12-31	CN¥1.34 Billion ≈ $196.59 Million	CN¥40.72 Million ≈ $5.96 Million	0.030x	-45.58%
2021-12-31	CN¥1.34 Billion ≈ $195.64 Million	CN¥74.46 Million ≈ $10.90 Million	0.056x	-77.85%
2020-12-31	CN¥1.33 Billion ≈ $193.90 Million	CN¥333.20 Million ≈ $48.76 Million	0.251x	+291.54%
2019-12-31	CN¥911.71 Million ≈ $133.41 Million	CN¥58.55 Million ≈ $8.57 Million	0.064x	-40.01%
2018-12-31	CN¥828.42 Million ≈ $121.22 Million	CN¥88.69 Million ≈ $12.98 Million	0.107x	-13.68%
2017-12-31	CN¥768.71 Million ≈ $112.49 Million	CN¥95.33 Million ≈ $13.95 Million	0.124x	-25.25%
2016-12-31	CN¥440.02 Million ≈ $64.39 Million	CN¥73.00 Million ≈ $10.68 Million	0.166x	-50.80%
2015-12-31	CN¥439.09 Million ≈ $64.25 Million	CN¥148.07 Million ≈ $21.67 Million	0.337x	+218.46%
2014-12-31	CN¥324.87 Million ≈ $47.54 Million	CN¥34.40 Million ≈ $5.03 Million	0.106x	-71.73%
2013-12-31	CN¥281.09 Million ≈ $41.13 Million	CN¥105.28 Million ≈ $15.41 Million	0.375x	-36.72%
2012-12-31	CN¥185.99 Million ≈ $27.22 Million	CN¥110.08 Million ≈ $16.11 Million	0.592x	--

About Zhejiang Shengda Pharm

SHG:603079 China Drug Manufacturers - Specialty & Generic

Market Cap

$326.95 Million

CN¥2.23 Billion CNY

Market Cap Rank

#14403 Global

#4278 in China

Share Price

CN¥11.82

Change (1 day)

-2.80%

52-Week Range

CN¥11.82 - CN¥21.99

All Time High

CN¥53.01